136 related articles for article (PubMed ID: 27496455)
1. Association Between HLA Type and Skin Cancer in Kidney Transplant Recipients.
Cegielska A; Dębska-Ślizień A; Moszkowska G; Imko-Walczuk B; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1608-10. PubMed ID: 27496455
[TBL] [Abstract][Full Text] [Related]
2. HLA alleles in renal transplant recipients with nonmelanoma skin cancer in southeastern Brazil.
Rogel CS; Souza-Santana FC; Marcos EVC; Ogawa MM; Basso G; Tomimori J
An Bras Dermatol; 2019 Jul; 94(3):287-292. PubMed ID: 31365656
[TBL] [Abstract][Full Text] [Related]
3. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
4. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
Wisgerhof HC; van der Boog PJ; de Fijter JW; Wolterbeek R; Haasnoot GW; Claas FH; Willemze R; Bouwes Bavinck JN
J Invest Dermatol; 2009 Dec; 129(12):2886-94. PubMed ID: 19571820
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients.
Fania L; Abeni D; Esposito I; Spagnoletti G; Citterio F; Romagnoli J; Castriota M; Ricci F; Moro F; Perino F; Mazzanti C; De Simone C; Peris K
G Ital Dermatol Venereol; 2020 Oct; 155(5):669-675. PubMed ID: 30251802
[TBL] [Abstract][Full Text] [Related]
9. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
10. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
[TBL] [Abstract][Full Text] [Related]
11. Genetics and nonmelanoma skin cancer in kidney transplant recipients.
Burke MT; Isbel N; Barraclough KA; Jung JW; Wells JW; Staatz CE
Pharmacogenomics; 2015 Jan; 16(2):161-72. PubMed ID: 25616102
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors of non melanoma skin cancers in kidney transplant patients].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
[TBL] [Abstract][Full Text] [Related]
13. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
[TBL] [Abstract][Full Text] [Related]
14. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of nonmelanoma skin cancer incidence rates in kidney transplant recipients in Ireland.
Bannon FJ; McCaughan JA; Traynor C; O'Brien K; Gavin AT; Maxwell AP; Comber H; Conlon PJ
Transplantation; 2014 Sep; 98(6):646-52. PubMed ID: 24798309
[TBL] [Abstract][Full Text] [Related]
17. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
18. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation.
Bock A; Bliss RL; Matas A; Little JA
Transplantation; 2004 Sep; 78(5):775-8. PubMed ID: 15371688
[TBL] [Abstract][Full Text] [Related]
20. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]